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We investigated the antidiabetic potential of proanthocyanidin and its oligomeric form in STZ-induced diabetic model rats
and db/db type 2 diabetic mice. Proanthocyanidin ameliorated the diabetic condition by signiﬁcant decreases of serum glucose,
glycosylated protein, and serum urea nitrogen as well as decreases of urinary protein and renal-AGE in STZ-induced diabetic rats
and decrease ofserum glucose as well as signiﬁcantdecrease of glycosylated protein in db/db type 2 diabetic mice. The suppression
of ROS generation and elevation of the GSH/GSSG ratio were also observed in the groups administered proanthocyanidin.
Moreover, proanthocyanidin, especially its oligomeric form, aﬀected the inﬂammatory process with the regulation of related
protein expression, iNOS, COX-2 and upstream regulators, NF-κB, and the IκB-α. In addition, it had a marked eﬀect on
hyperlipidemia through lowering signiﬁcant levels of triglycerides, total cholesterol, and NEFA. Moreover, expressions in the
liver of SREBP-1 and SREBP-2 were downregulated by the administration of proanthocyanidins. The protective eﬀect against
hyperglycemia and hyperlipidemia in type 1 and 2 diabetic models was signiﬁcantly strong in the groups administered the
oligomeric rather than polymeric form. This suggests that oligomers act as a regulator in inﬂammatory reactions caused by
oxidative stress in diabetes.
1.Introduction
Diabetesmellitusisachronicmetabolicdisorderthatcontin-
ues to present a major worldwide health problem. It is char-
acterized by hyperglycemia, an abnormal elevation of the
blood glucose level, which has been associated with oxida-
tive-stress [1]. Numerous studies demonstrated that oxygen
free radicals are generated as a result of hyperglycemia and
cause various complications of diabetes, such as nephropa-
thy, retinopathy, and neuropathy[2, 3]. Indiabetes, products
of lipid peroxidation, advanced glycation end products
(AGEs), and damaged DNA accumulate and eventually
result in pathological diabetic complications [4–6]. Fur-
thermore, the development of diabetes is closely related to
inﬂammatory processes. In the absence of an appropriate
compensatory response from the endogenous antioxidant
network against glucotoxicity and lipotoxicity caused by
hyperglycemia and hyperlipidemia under diabetes, oxidative
stress becomes marked, leading to activation of the stress-
sensitive intracellular signaling pathway [7, 8]. Accordingly,
the attenuation of oxidative stress and regulation of stress-
sensitive signaling pathways have been considered as ways to
alleviate diabetes and diabetic complications.
Persimmon (Diospyros kaki), a deciduous fruit, is culti-
vated in Japan, Korea, China, Brazil, and Italy. It contains
many bioactivecompounds,suchaspolyphenols,ﬂavonoids,
terpenoids, steroids, dietary ﬁber, carotenoids, and minerals
[9]. In particular, persimmon is a proanthocyanidin-rich
food, with higher contents in the peel than in the pulp [10,
11]. Proanthocyanidin is known as condensed tannin, a
member of a speciﬁc group of polyphenolic compounds,
and it has been reported to exhibit powerful antioxidant
activity [12,13].To elucidatetheprotectiveroleofproantho-
cyanidin against diabetes in relation to its polymerization,
we extracted proanthocyanidin from persimmon peel and
then disintegrated polymers and oligomers from it [14], as2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Fractionation of polymers and oligomers from proanthocyanidin of persimmon fruit.
shown in Figure 1. The degree of oligomeric polymerization
was estimated as 3.3 based on quantitative HPLC analysis of
thiol degradation products [15], while the unit rates of (−)-
epigallocatechin, (−)-epicatechin,(−)-epigallocatechin 3-O-
gallate, and (−)-epicatechin 3-O-gallate in oligomers were
determined as 47, 15, 31, and 6%, respectively.
Proanthocyanidin polymers have antioxidative, antifun-
gal, and anticancer properties [10, 16, 17]. However, the
protective potential of proanthocyanidin from persimmon
peelagainstoxidativestressandinﬂammation indiabeticrats
has not been reported to date. Based on our previous studies
[14, 18], the antidiabetic potential of proanthocyanidin
and its oligomeric form in vivo in streptozotocin (STZ)-
induced diabetic model rats and db/db type 2 diabetic mice
is reviewed herein. Furthermore, the protective mechanisms
against diabetes have been elucidated.
2.EffectofProanthocyanidinin STZ-Induced
DiabeticRats
2.1. Hematological and Renal Functional Parameters. Under
the diabetic condition, glucose itself and an increase in pro-
tein glycosylation induced by hyperglycemia are signiﬁcant
sources of free radicals and inducers of oxidative stress [19].
The administration of proanthocyanidin at 10mg/kg body
weight/day to STZ-induced diabetic rats led to signiﬁcant
decreases in the levels of glucose and glycosylated protein
(Table 1). In particular, the oligomeric proanthocyanidin-
administered rats showed a signiﬁcant declinein these values
of glucose and glycosylated protein. This indicated that
proanthocyanidin attenuated the pathological condition of
diabetes by controlling blood glucose and protein glycosyla-
tion. In addition, the inhibition of renal AGE formation by
Table 1: Serum glucose and glycosylated protein levels in STZ-
induced diabetic rats.
Group Glucose Glycosylated protein
(mg/dL) (nmol/mgprotein)
ND 116.5 ± 4.2b 28.30 ± 1.20b
DC 591.3 ± 18.4 46.84 ± 1.42
DP 583.8 ± 18.0 44.11 ± 1.13
DO 532.8 ± 9.0a 40.60 ± 1.90a
The results are expressed as the mean ± SEM. Signiﬁcance: aP < 0.05, bP <
0.001versusDC.ND,nondiabeticnormalrats;DC,diabeticcontrolrats;DP,
polymeric proanthocyanidin 10mg/kg body weight-treated diabetic rats;
DO, oligomeric proanthocyanidin 10mg/kg body weight-treated diabetic
rats.
proanthocyanidin would be associated with attenuation of
the pathogenesis of diabetic complications, since evidence
that the renal accumulation of AGEs is linked to the patho-
genesis of various diabetic complications has been wellestab-
lished [20]. The levels showed a signiﬁcant increase in the
diabetic control group; however, the decrease in AGEs was
shown in both oligomeric proanthocyanidin- and polymeric
proanthocyanidin-administered rats,butonlytheoligomeric
proanthocyanidin-administered rats showed a signiﬁcant
eﬀect(Figure 2). Our studyalso showed that renal functional
markers were improved through signiﬁcant downregulation
ofserumurea nitrogenand declineofurinary proteinlevelby
proanthocyanidin (Table 2). The oligomeric proanthocyani-
din exerted a signiﬁcantly stronger protective activity than
the polymeric form, suggesting that polymerization aﬀects
the functional properties of proanthocyanidin. These results
are in agreement with studies showing that the maintenance
of the antioxidative status plays a crucial role in protecting
against renal insuﬃciency [21, 22].Evidence-Based Complementary and Alternative Medicine 3
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Figure 2: AGE levels in the kidney of STZ-induced diabetic rats.
Ther esultsar ee xpr essedasthemean±SEM.Signiﬁcance: aP <0.05
versus DC. ND, nondiabetic normal rats; DC, diabetic control rats;
DP, polymeric proanthocyanidin 10mg/kg body weight-treated
diabetic rats; DO, oligomeric proanthocyanidin 10mg/kg body
weight-treated diabetic rats.
Table 2: Renal function parameters in STZ-induced diabetic rats.
Group Serum urea nitrogen Urinary protein
(mg/dL) (mg/day)
ND 19.3 ± 0.8b 13.10 ± 0.76
DC 33.1 ± 1.5 23.02 ± 4.78
DP 30.3 ± 0.6 16.64 ± 2.19
DO 24.0 ± 1.3a 13.06 ± 0.22
T h er e s u l t sa r ee x p r e s s e da st h em e a n± SEM. Signiﬁcance: aP < 0.01, bP <
0.001versusDC.ND,nondiabeticnormalrats;DC,diabeticcontrolrats;DP,
polymeric proanthocyanidin 10mg/kg body weight-treated diabetic rats;
DO, oligomeric proanthocyanidin 10mg/kg body weight-treated diabetic
rats.
2.2. Reactive Oxygen Species (ROS) Generation and Reduced
Glutathione (GSH)/Oxidized Glutathione (GSSH) Redox Bal-
ance. Oxidative stress occurs when the production of ROS
overwhelms antioxidant defenses via antioxidants and anti-
oxidative enzymes. This oxidative stress leads to cellular
damage and is a causative factor in chronic degenerative
diseases. In biological systems, antioxidants such as GSH,
a major nonenzymatic antioxidant involved in the main-
tenance of the redox balance, ameliorate cellular oxidative
damage. At cellular and molecular levels, redox imbalance
causes the activation of redox-sensitive transcription factors
that lead to inﬂammation [23]. Therefore, enhanced oxida-
tive stress due to uncontrolled ROS is a major factor in
both acute and chronic inﬂammation and inﬂammatory-
related diseases including diabetes [24]. The eﬀect of proan-
thocyanidin administration on ROS generation in the STZ-
diabetic rat model is shown in Figure 3(a).T h eg e n e r a t i o n
of ROS was signiﬁcantly elevated in the diabetic control
group compared with the normal group, while the adminis-
tration of proanthocyanidin, both oligomers and polymers,
led to a signiﬁcant decrease inROSgeneration. Figures3(b)–
3(d) illustrate the levels of GSH and GSSG and their ratio.
The GSH level signiﬁcantly decreased in the diabetic control
group; however, it was signiﬁcantly increased in the poly-
meric proanthocyanidin- and oligomeric proanthocyanidin-
administered rats compared to the diabetic control group
(Figure 3(b)). The GSSG level was signiﬁcantly elevated
in the diabetic control group, but it was significantly
reduced in the polymeric proanthocyanidin- and oligomeric
proanthocyanidin-administered rats (Figure 3(c)). In addi-
tion, as presented in Figure 3(d), the GSH/GSSG ratio
showed a signiﬁcantly marked decrease in the diabetic con-
trol group, while it increased in the polymeric proanthocya-
nidin- and oligomeric proanthocyanidin-administered rats,
compared to the control group. The oligomer-treated rats
had a higher ratio of GSH/GSSG than the polymer-treated
rats throughanelevationinGSH and adeclinein GSSG.The
increase in ROS generation under diabetes was attenuated
by proanthocyanidin. This suggests that proanthocyanidin
would probably ameliorate diabetic oxidative stress. Its
actionsarepossiblyrelatedtoupregulationoftheGSH/GSSG
ratio through an increase in GSH and decline in GSSG. The
elevation of the GSH/GSSG ratio and suppression of ROS
generation may be the primary role of proanthocyanidin in
ameliorating oxidative stress and maintaining the redox bal-
ance. In diabetes mellitus, oxidative stress may be attributed
to a combination of hyperglycemia-induced glycoxidation,
sorbitol system activation, and reduced GSH synthesis due
to a limited hexose monophosphate shunt. It has been
reported that, under hyperglycemic conditions, as much
as 30% of glucose is shunted to the polyol pathway [25],
causing a marked depletion of NADPH, and, consequently,
a signiﬁcant decrease in the GSH level. Our current data on
the GSH/GSSG ratio are in line with the results of other,
which demonstrated that elevation of the GSH/GSSG ratio
is eﬀective for ameliorating oxidative stress under diabetes
[26].
2.3. Protein Expression Related to Inﬂammatory Processes.
Since redox imbalance is causally linked to inﬂammatory
processes [27], we evaluated the expression levels of some
major factors implicated in inﬂammation in the diabetic
rat model. The inﬂammatory process is regulated by
cyclooxygenase-2 (COX-2) and nuclear factor-κB( N F - κB).
ROS induce the activation of NF-κBa c t i v i t y ,a n dN F - κB,
in turn, up-regulates the transcription of genes that encode
enzymes such as inducible nitric oxide synthase (iNOS)
and COX-2 [27, 28]. The present results showed that the
protein levels of COX-2 and iNOS were increased in the
diabetic oxidative rat model. As observed in Figure 4(d),
the iNOS protein level in diabetic rats was increased
although it did not have signiﬁcant diﬀerence, but it was
signiﬁcantly decreased by proanthocyanidin administration;
inhibition of iNOS protein expression was signiﬁcantly
strongintheoligomericproanthocyanidin-administered rats
thanthepolymericproanthocyanidin-administered rats.The
expression of COX-2 protein (Figure 4(c)) was up-regulated4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: ROS generation, GSH and GSSG levels, and their ratios in the kidney of STZ-induced diabetic rats. (a) ROS generation, (b) GSH
levels, (c) GSSG levels, (d) GSH/GSSG ratio. The results are expressed as the mean ± SEM. Signiﬁcance: aP< 0.05, bP < 0.01, cP < 0.001
versus DC. ND, nondiabetic normal rats; DC, diabetic control rats; DP, polymeric proanthocyanidin 10mg/kg body weight-treated diabetic
rats; DO, oligomeric proanthocyanidin 10mg/kg body weight-treated diabetic rats.
in the diabetic control group compared with the nondiabetic
group, while the oligomeric proanthocyanidin-administered
group showed signiﬁcant inhibition of the expression. Feng
et al. [29] reported that ROS induce the expression of COX-
2 protein, the key enzyme in proinﬂammatory prostanoid
synthesis, and COX-2 is induced readily by cytokines,
hormones, growth factors, and tumor promoters in selected
tissues [30, 31]. In addition, iNOS is also readily inducible
by proinﬂammatory cytokines and has a close relationship
with ROS generation. The administration of oligomeric
proanthocyanidin suppressed the high-level expression of
these proteins under diabetes. This suggests that modulation
ofCOX-2andiNOSexpressionsmaycontributetoanimpor-
tant protective role of proanthocyanidin against diabetes.
A molecular explanation supporting the aforementioned
ﬁndings comes from the present results on NF-κBe x p r e s -
sion. The NF-κB complex is a heterodimer of two subunits,
p50 and p65, which exist in the cytoplasm in an inactive
form, and it is related to the inhibitory subunit, inhibitor
protein κB-α (IκB-α). Molecular investigations revealed
that inﬂammation and ROS stimulate NF-κBa c t i v a t i o n
by enhancing the dissociation of cytoplasmic NF-κBf r o m
IκB-α, thereby allowing NF-κB to migrate to the nucleus
[32], where it binds to promoters of NF-κB-regulated
genes to initiate gene transcription [33]. In the present
study, a signiﬁcant increase in the NF-κBp65 protein level
and signiﬁcant reduction of the IκB-α protein level were
observedinthediabeticrat(Figures4(a)and4(b)).However,Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: NF-κB, IκB-α, COX-2, and iNOS protein levels in the kidney of STZ-induced diabetic rats. (a) NF-κB, (b) IκB-α,( c )C O X - 2 ,( d )
iNOS. The results are expressed as the mean ± SEM. Signiﬁcance: aP < 0.05, bP < 0.01, cP < 0.001 versus DC. ND, nondiabetic normal rats;
DC, diabetic control rats; DP, polymeric proanthocyanidin 10mg/kg body weight-treated diabetic rats; DO, oligomeric proanthocyanidin
10mg/kg body weight-treated diabetic rats.
the administration of proanthocyanidin led to a decrease in
NF-κBp65 and elevation of IκB-α protein, indicating that
proanthocyanidin suppressed the translocation of NF-κB
to the nucleus, where it binds to the promoters of NF-
κB-regulated genes and initiates gene transcription. In
particular, in proanthocyanidin from persimmon peel, the
oligomeric form exerted stronger eﬀects on inﬂammatory
protein regulation than the polymeric form, suggesting
the crucial role of the polymerization of proanthocyani-
din in inﬂammation-related conditions. Our ﬁndings on
NF-κBp65, COX-2, and iNOS protein levels indicate the
crucial protective role of proanthocyanidin through its
antidiabetic action by modulating key proinﬂammatory
genes.
3.ProtectiveActivityofProanthocyanidin
fromType2 Diabetes with
RegulationofHyperlipidemia
3.1. Hematological Change and Hepatic Lipid Contents. Dia-
betes represents progressive and cumulative damage caused
by cellular glucose and lipid metabolites. Therefore, the
regulation of circulating metabolites including glucose, free6 Evidence-Based Complementary and Alternative Medicine
Table 3: Hematologicalanalyses in mouse model of type 2 diabetes.
Group Dose
(mg/kg B.W./day)
Glucose
(mg/dL)
Glycosylated protein
(nmol/mgprotein)
TG
(mg/dL)
TC
(mg/dL)
NEFA
(mEq/L)
m/m — 127.8 ± 13.4c 57.3 ± 7.5b 68.4 ± 5.8c 68.8 ± 2.2c 0.72 ± 0.07c
db/db
Vehicle — 663.4 ± 58.4 112.1 ± 12.6 152.2 ± 20.2 167.5 ± 5.9 1.47 ± 0.07
Polymers 10 607.8 ± 69.7 98.6 ± 18.3 76.3 ± 9.5b 150.3 ± 3.9a 1.06 ± 0.07c
Oligomers 10 572.7 ± 70.5 75.5 ± 8.9a 75.2 ± 3.3c 149.8 ± 4.9a 1.06 ± 0.07c
The results are expressed as the mean ± SEM. Signiﬁcance: aP < 0.05, bP < 0.01, cP < 0.001 versus db/db mice treated with vehicle.
Table 4: Liver weight and hepatic TG and TC contents in mouse model of type 2 diabetes.
Group Dose (mg/kg B.W./day) Weight (g) TG (mg/liver/10 g B.W.) TC (mg/liver/10 g B.W.)
m/m —1 . 2 1 ± 0.02b 23.5 ± 4.6b 32.2 ± 1.7c
db/db
Vehicle — 4.25 ± 0.15 78.2 ± 9.2 54.0 ± 2.5
Polymers 10 4.02 ± 0.10 59.1 ± 3.4 51.7 ± 1.7
Oligomers 10 3.98 ± 0.20 56.9 ± 2.1a 36.8 ± 3.6c
The results are expressed as the mean ± SEM. Signiﬁcance: aP < 0.05, bP < 0.01, cP < 0.001 versus db/db mice treated with vehicle.
fattyacids(FFA)andcanbeconsideredasapartofmetabolic
modulation in various tissues. In this study, we investigated
glucose and glycosylated protein as hematologic factors
of hyperglycemia, and triglycerides (TG), total cholesterol
(TC), and nonesteriﬁed fatty acids (NEFA) as indicators
of hyperlipidemia. We conﬁrmed that db/db mice showed
hyperglycemia as well as hyperlipidemia. As shown in
Table 3, the levels of glucose and glycosylated protein in the
db/db control group were increased signiﬁcantly compared
with the m/mgroup as age-matched nondiabetic misty mice.
Although the glucose level was not signiﬁcantly decreased
by the administration of proanthocyanidins, a tendency
to reduce the glucose level was exhibited by oligomers.
Regarding glycosylated protein, oligomer administration led
to a signiﬁcant decrease in the level. Moreover, the serum
concentrations of TG, TC, and NEFA were signiﬁcantly
elevated in the db/db control group compared with the
m/m group; these concentrations were signiﬁcantly reduced
in the proanthocyanidin-administered groups. However,
no signiﬁcant diﬀerence between polymer- and oligomer-
administered groupswas observed.Inaddition, thesehepatic
concentrations of TG and TC were signiﬁcantly decreased
by proanthocyanidin administration (Table 4). In particular,
the decrease in these levels was more signiﬁcant in the group
administered oligomers than polymers.
From these results, the administration of proanthocya-
nidin ameliorated hyperglycemia through a decline in the
serum level of glucose and glycosylated protein. In addi-
tion, it had a strong eﬀect on hyperlipidemia through
lowering TG, TC, and NEFA. The protective eﬀect against
hyperglycemia and hyperlipidemia was greater in the group
administered the oligomeric rather than polymeric form. An
increase in the level of polymerization leads to the elevation
of lipase activity, leading to dietary fat digestion and
absorption [34, 35]. Therefore, polymeric proanthocyanidin
with high-level polymerization may suppress fat absorption
in the gastrointestinal tract; consequently, the inﬂow of
lipidemic metabolites into the blood may be inhibited. Even
if lipase activity is decreased by oligomerization, oligomeric
proanthocyanidin improves not only hyperlipidemia but
also hepatic lipid accumulation in db/db mice through
mechanisms distinct from those of the polymeric form.
3.2. Biomarkers Associated with Oxidative Stress. Hyper-
glycemia and elevated FFA levels result in the generation of
ROS, and, consequently, increase oxidative stress. ROS not
only directly damage cells by oxidizing DNA, proteins, and
lipids,butalso indirectlydamage thembyactivating avariety
of stress-sensitive intracellular signaling pathways such as
NF-κB, p38 mitogen-activated protein kinase (MAPK),
NH2-terminal Jun kinase/stress-activated protein kinase,
hexosamines, protein kinase C, AGE/receptor for AGE
(RAGE), and others. Activation of these pathways results in
the increased expression of numerous gene products that
cause cellular damage and play a major role in the etiology
of the later-stage complications of diabetes [36]. Thus, the
upregulation of endogenous antioxidative systems and sup-
pression of oxidative stress are important factors to ame-
liorate diabetes and its complications. As shown in Table 5,
the groups administered polymers and oligomers showed
a decrease in the thiobarbituric acid-reactive substance
(TBARS) level, and the elevation in ROS generation was
decreased by proanthocyanidin administration. The changes
in TBARS and ROS generation were signiﬁcantly more
pronounced on the administration of oligomers rather
than polymers. Our results showed that ROS generation
and lipid peroxidation were increased in db/db mice. ROS
generation induces the oxidation of membrane lipids as
one of the primary events in oxidative cellular damage.
Lipid peroxidation also leads to oxidant production from
many molecules, and thus ampliﬁes oxidative damage [37].
Therefore,ourresultssuggestthatdb/dbmiceshowincreasedEvidence-Based Complementary and Alternative Medicine 7
Table 5: Hepatic biomarkers associated with oxidative stress in mouse model of type 2 diabetes.
Group Dose
(mg/kg B.W./day)
TBARS
(nmol/mgprotein)
ROS generation
(%)
GSH
(μmol/mg protein)
GSSG
(μmol/mg protein) GSH/GSSG
m/m —0 . 6 3 ± 0.07a 100.3 ± 9.3c 6.63 ± 0.36a 4.65 ± 0.52 1.49 ± 0.12c
db/db
Vehicle — 1.18 ± 0.20 248.2 ± 30.3 4.91 ± 0.56 5.67 ± 0.57 0.86 ± 0.03
Polymers 10 1.11 ± 0.12 206.5 ± 15.7 4.63 ± 0.22 5.45 ± 0.24 0.85 ± 0.02
Oligomers 10 0.71 ± 0.07a 185.1 ± 12.3 4.07 ± 0.36 3.76 ± 0.31a 0.98 ± 0.05b
The results are expressed as the mean ± SEM. Signiﬁcance: aP < 0.05, bP < 0.01, cP < 0.001 versus db/db mice treated with vehicle.
oxidative damage due to an elevation of ROS generation
induced by hyperglycemia and hyperlipidemia.
Moreover, the db/db control group showed signiﬁcant
decline of GSH/GSSG ratios through the decrease in the
GSH level and increase in the GSSG level compared with the
m/m group (Table 5). The oligomer-treated group showed
elevated GSH/GSSG ratios due to the signiﬁcant decrease
in GSSG levels and slight increase in GSH levels, whereas
the polymer-treated group did not show a signiﬁcant eﬀect.
During ROS overproduction, the intracellular antioxidant
GSH is oxidized to GSSG, which is then reconverted to GSH
byGSHreductase.TheGSH/GSSGratiodeﬁnestheso-called
GSH redox state, which plays an important role in cellular
activation, gene expression, mRNA stability, protein folding,
metabolic regulation, and cell protection against oxidative
damage [38]. Decreased GSH and increased GSSG and,
consequently, down-regulation of the GSH/GSSG ratio in
db/db mice were implicated in the disruption of the intracel-
lular antioxidative system. In our study, the administration
of oligomeric proanthocyanidin attenuated the increase in
ROS generation and lipid peroxidation and elevated the
GSH/GSSG ratio, whereas polymeric proanthocyanidin did
not show any eﬀect. The antioxidative eﬀect of oligomeric
proanthocyanidin is probably associated with the inhibition
of glycosylated protein levels, because it is generated as glu-
cose reacts with an amino group to form a labile Schiﬀ base
that is highly prone to oxidation and free radical generation
[39]. From our data, oligomeric proanthocyanidin exhibited
moreeﬀectiveantioxidativeandantihyperlipidemicactivities
than polymeric proanthocyanidin. This suggests that the
oligomerizationofproanthocyanidin playsanimportantrole
in type 2 diabetes.
3.3. Regulation of Transcription Factors Related to Lipid Meta-
bolism. Lipid homeostasis is regulated by a family of mem-
brane-bound transcription factors called sterol regulatory
element binding proteins (SREBPs). SREBP-1 is a key tran-
scription factor that nutritionally regulates the hepatic gene
expression of lipogenic enzymes and TG deposition in the
liver [40]. On the other hand, SREBP-2 regulates genes
involved in cholesterol synthesis through the cleavage of its
precursorformtoan activenuclearformvia interactionwith
SREBP cleavage activating protein and protease in a sterol-
dependent manner [41]. Upregulations of SREBP-1 and
SREBP-2 were reported in leptin-resistant mice such as IRS-
2−/− and FVBdb/db mice [42, 43]. In this study, the increase
in hepatic SREBP-1 and SREBP-2 in db/db mice was signif-
icantly down-regulated by the administration of proantho-
cyanidin, especially in the oligomeric form (Figure 5). This
was probably related to the inhibition of hepatic TG and
TC accumulations. Furthermore, peroxisome proliferator-
activated receptors (PPARs), with three isoforms (α, δ,a n d
γ), are also involved in the long-term regulation of lipid
metabolism, and their activity is modulated by endogenous
lipid-derived ligands. When PPARα is activated, it promotes
fatty acid oxidation, ketone body synthesis, and glucose
sparing [44].In addition,thedb/dbcontrol group exhibited a
signiﬁcantly marked decrease in hepatic PPARα expressions;
however, administrations of both polymers and oligomers
slightly increased PPARα expressions (Figure 5(c)). In the
current study, hepatic PPARα was decreased in db/db mice;
however, it was increased slightly by proanthocyanidin
administration. In our study, we clariﬁed that proantho-
cyanidin, especially in its oligomeric form, exhibits an eﬀect
on regulations of both PPARα and SREBPs.
3.4. Modulations of Oxidative Stress-Sensitive Intracellular
Signaling Pathway. Undertype2diabetes,thestress-sensitive
intracellular signaling pathway is altered. In particular, one
major intracellular target of hyperglycemia and oxidative
stress is the transcription factor NF-κB. NF-κB can be acti-
vated by a wide array of exogenous and endogenous stimuli
including hyperglycemia, elevated FFA, ROS, tumor necrosis
factor-α,i n t e r l e u k i n - 1 β, other proinﬂammatory cytokines,
AGE-binding RAGE, and p38 MAPK. The aberrant regula-
tionofNF-κBis associatedwith anumber ofchronic diseases
including diabetes and atherosclerosis [45]. NF-κBi sp r e s e n t
in the cytoplasm as an inactive heterodimer, consisting of
p50 and p65 subunits complexed with an inhibitor protein
subunit, IκB. After stimulation, IκB was phosphorylated
by the activation of a serine kinase cascade. This event
primes IκB as a substrate for ubiquitination and subsequent
degradation, facilitating NF-κB heterodimer translocation
to the nucleus. NF-κB regulates the expression of a large
numberofgenes,includinggrowthfactors, proinﬂammatory
cytokines, and others [45, 46]. NF-κBi si n v o l v e di nt h e
regulation of COX-2 and iNOS expressions that mediate
inﬂammatory processes [28]. NF-κB expression in the db/db
control group was up-regulated, while it was signiﬁcantly
suppressed by the administration of oligomers (Figure 6(a)).
IκB-α expression was down-regulated in the db/db con-
trol group, but its expression intensity was signiﬁcantly8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Hepatic SREBP-1, SREBP-2, and PPARα protein levels in mouse model of type 2 diabetes. (a) SREBP-1, (b) SREBP-2, (c) PPARα.
T h er e s u l t sa r ee x p r e s s e da st h em e a n± SEM. Signiﬁcance: aP < 0.05, bP < 0.01, cP < 0.001 versus db/db mice treated with vehicle. m/m,
nondiabetic misty mice; Veh, db/db vehicle-treated mice; P, db/db mice treated with polymeric proanthocyanidin (10mg/kg body weight);
O, db/db mice treated with oligomeric proanthocyanidin (10mg/kg body weight).
increased by oligomer administration. On the other hand,
the polymer-treated group showed no signiﬁcant change in
NF-κBa n dI κB expressions (Figures 6(a) and 6(b)). How-
ever, proanthocyanidin administration, especially oligomers
rather than polymers, suppressed protein expressions of
COX-2 and iNOS (Figures 6(c) and 6(d)). In db/db mice,
hepatic NF-κB was up-regulated with the down-regulation
of IκBc o m p a r e dw i t hm/m mice, while the administration
of proanthocyanidin, especially in its oligomeric form, led to
the down-regulation of NF-κB with the upregulation of IκB.
NF-κB activation induces insulin resistance by lipid/fatty
acid infusion and the inhibition of insulin signaling by
lipid metabolites such as diacylglycerol and ceramide [47].
Accordingly, our results suggest that the regulation of NF-
κBa n dI κB by oligomers is associated with the ame-
lioration of hyperlipidemia and hyperglycemia. Moreover,
COX-2 and iNOS mediate inﬂammation-mediated/induced
insulin resistance. The expressions were increased in db/dbEvidence-Based Complementary and Alternative Medicine 9
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Figure 6: Hepatic NF-κB, IκB-α, COX-2, and iNOS protein levels in mouse model of type 2 diabetes. (a) NF-κB, (b) IκB-α,( c )C O X - 2 ,( d )
iNOS.Theresultsareexpressed asthemean±SEM.Signiﬁcance: aP <0.05, bP <0.01, cP <0.001versusdb/dbmicetreated withvehicle.m/m,
nondiabetic misty mice; Veh, db/db vehicle-treated mice; P, db/db mice treated with polymeric proanthocyanidin (10mg/kg body weight);
O, db/db mice treated with oligomeric proanthocyanidin (10mg/kg body weight).
compared with m/m mice. COX-2 and iNOS expressions
were up-regulated under insulin resistance, obesity, hyper-
glycemia, and oxidative stress [48]. Their down-regulations
by oligomers shown by the present results indicated the
regulation of hyperlipidemia with the inhibition of TG and
TC deposition. The present results suggest the crucial role of
oligomers in stress-activated signaling pathways such as NF-
κB, COX-2, and iNOS.
4.Conclusion
Proanthocyanidin exerted a protective role against hyper-
glycemia and hyperglycemia-related changes through mod-
ulating glucose, glycosylated protein, serum urea nitrogen,
urinary protein, and renal AGEs in STZ-diabetic rats. Based
on the results, we propose that the suppression of oxida-
tive stress-related inﬂammation is a plausible mechanism10 Evidence-Based Complementary and Alternative Medicine
underlying the protective eﬀect of proanthocyanidin in
diabetic rats. The administration of proanthocyanidin to
STZ-induced type 1 diabetic rats and db/db type 2 diabetic
mice attenuated oxidative stress through the inhibition of
lipid peroxidation, ROS generation, and elevation of the
GSH/GSSG ratio. In addition, proanthocyanidin regulated
the expression of proteins related to inﬂammation such
a si N O S ,C O X - 2 ,N F - κBp65, and IκB-α protein. In par-
ticular, the oligomeric form of proanthocyanidins amelio-
rated oxidative damage and lipid deposition in the liver
more eﬀectively than the polymeric form. Oligomerization
may be associated with ameliorations of oxidative stress
and abnormal lipid metabolism. The oligomeric form of
proanthocyanidins reversed hyperlipidemia in parallel with
regulations of hepatic SREBP-1 and SREBP-2 expressions.
The present study suggests that proanthocyanidins, espe-
cially oligomers, act as a regulator in inﬂammatory reactions
caused by oxidative stress in diabetes.
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